Transplacental passage of anti‐thyroid auto‐antibodies in a pregnant woman with auto‐immune thyroid disease

We report the intra‐uterine and postnatal thyroid status of a newborn, whose mother, affected with Hashimoto's thyroiditis superimposed on a previous Graves' disease, again became hyperthyroid during the third trimester of pregnancy. The mother had very high levels of anti‐thyroid auto‐antibodies, including TSH receptor auto‐antibodies (TRAb) measured as TSH‐binding inhibiting auto‐antibodies (TBIAb). In order to exclude fetal thyroid dysfunction due to passive transplacental transfer of TRAb, fetal blood samples were obtained by cordocentesis at 21, 27 and 32 weeks of gestation. A transplacental transfer of TRAb was already seen at 21 weeks, but no alteration of fetal thyroid function was present at that time. In the following weeks, a rise in TRAb and circulating thyroid hormones was observed both in the fetus and mother, accompanied by overt hyperthyroidism in the mother and by growth retardation in the fetus. At birth, TRAb were shown to have stimulating activity both in the newborn and mother. This report documents the early transplacental passage of thyroid auto‐antibodies and underlines the importance of close follow‐up of pregnant women with auto‐immune thyroid disorders. Copyright © 1999 John Wiley & Sons, Ltd.

[1]  J. Lazarus,et al.  The thyroid and pregnancy , 1993, British journal of obstetrics and gynaecology.

[2]  K. Nicolaides,et al.  Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. , 1991, The New England journal of medicine.

[3]  M. Parmentier,et al.  Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies , 1990, Molecular and Cellular Endocrinology.

[4]  J. S. Lee,et al.  Pregnancy induces the presence of a thyroid-stimulating antibody in a thyrotropin-binding inhibitory immunoglobulin positive, hypothyroid woman with transient thyrotoxicosis in offspring. , 1990, Journal of the Formosan Medical Association = Taiwan yi zhi.

[5]  R. Mortimer,et al.  Graves'DISEASE IN PREGNANCY: TSH RECEPTOR BINDING INHIBITING IMMUNOGLOBULINS AND MATERNAL AND NEONATAL THYROID FUNCTION , 1990, Clinical endocrinology.

[6]  J. Perheentupa,et al.  Multivariate Analysis of Psychomotor Development in Congenital Hypothyroidism , 1989, Acta paediatrica Scandinavica.

[7]  R. Volpe,et al.  Graves' disease in pregnancy years after hypothyroidism with recurrent passive-transfer neonatal Graves' disease in offspring. Therapeutic considerations. , 1984, The American journal of medicine.

[8]  Anthony L. Johnson,et al.  Preliminary Communication Thyro-endocrine pathology, obstetric morbidity and schizophrenia: survey of a hundred families with a schizophrenic proband , 1978, Psychological Medicine.

[9]  D. Edelman,et al.  A standard of fetal growth for the United States of America. , 1976, American journal of obstetrics and gynecology.

[10]  L. Lubchenco,et al.  Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. , 1966, Pediatrics.

[11]  J. Mckenzie,et al.  Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. , 1992, Thyroid : official journal of the American Thyroid Association.

[12]  F. Daffos Fetal blood sampling. , 1989, Annual review of medicine.